{"id":"sal056-56-5-g","safety":{"commonSideEffects":[{"rate":null,"effect":"Oropharyngeal candidiasis"},{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dysphonia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"SAL056 acts as a topical anti-inflammatory agent when delivered directly to the respiratory tract via inhalation. By activating glucocorticoid receptors on immune cells and airway epithelium, it suppresses the production of pro-inflammatory cytokines and reduces mucus production, airway edema, and eosinophilic infiltration. This mechanism makes it suitable for chronic inflammatory airway diseases.","oneSentence":"SAL056 is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:33:21.476Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma (maintenance therapy)"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT07028320","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk","status":"COMPLETED","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2021-12-03","conditions":"Postmenopausal Women With Osteoporosis","enrollment":493}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Teriparatide for Injection"],"phase":"phase_3","status":"active","brandName":"SAL056 (56.5μg)","genericName":"SAL056 (56.5μg)","companyName":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","companyId":"shenzhen-salubris-pharmaceuticals-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SAL056 is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue. Used for Asthma (maintenance therapy), Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}